A dozen years ago, Vioxx was given the axe. This pain medicine, developed by Merck, was considered to be a menace. Because the risk of heart attacks were much higher than expected.
Continue reading NSAID Safety?
Pfizer. AstraZeneca. Eli Lilly. Novartis. GlaxoSmithKline (GSK) . And, now Bayer and Merck.
Bayer will be taking over the consumer care (and non-prescription drug) business of Merck. For $ 14.2 billion, Bayer will be come the second largest provider of OTC (over-the-counter) products;’ second mostly because of the merger of Novartis and GSK that we discussed yesterday. And, there’s another part of this deal- Bayer will co-develop a series of cardiovascular therapies (for which Merck will shell out about $ 2 billion).
Continue reading And one really does make sense
